Alternate paclitaxel-gemcitabine and paclitaxel-vinorelbine biweekly administration in non-small cell lung cancer patients: A phase II study

Anticancer Research

Volumn 26, Issue 2 B, 2006, Pages 1397-1402

  Dimitroulis, J ^a   Toubis, M ^a   Antoniou, D ^a   Marosis, C ^a   Armenaki, U ^a   Stathopoulos, G P ^b,d   Giamboudakis, P ^a   Veslemes, M ^a   Michalopoulou, P ^a   Christou, F ^a   Georgatou, N ^a   Grigoratou, T ^a   Karaindros, D ^c   Katis, K ^c  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

^b Errikos Dunant Hospital   (Greece)

^c THRIASIO GENERAL HOSPITAL   (Greece)

^d NONE   (Greece)

Author keywords

Gemcitabine; Non small cell lung cancer; Paclitaxel; Vinorelbine

Indexed keywords

CYTOTOXIC AGENT; DEXAMETHASONE; GEMCITABINE; NAVELBINE; ONDANSETRON; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ALLERGY; ALOPECIA; ANEMIA; ARTICLE; ASTHENIA; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; FEMALE; FEVER; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUTROPENIA; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; PATIENT COMPLIANCE; TREATMENT OUTCOME; VINBLASTINE;

EID: 33645838189     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Shepherd FA, Dancey J, Ramlau R et al: Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol 18: 2095-2103, 2000.
2. Casper ES, Gralla RI, Kelsey DP, Cvitkovic E and Golbey RB: Phase II study of high-dose cis-diammine-dichloroplatinum (II) in the treatment of non-small-cell lung cancer. Cancer Treat Rep 63: 2107-2109, 1979.
3. Kelsen DT, Gralla RI, Casper ES et al: Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung, randomized trial investigation in two dosage schedule. Ann Intern Med 95: 414-420, 1981.
4. Ruckdeschel JC, Finkelstein DM, Mason BA and Creech RH: Chemotherapy for metastatic non-small-cell bronchogenic carcinoma EST 2575, generation V - a randomized comparison of four cisplatin containing regimens. J Clin Oncol 3: 72-79, 1985.
5. Non-Small Cell Lung Cancer Collaborative Groups: Chemotherapy in non-small-cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311: 899-909, 1995.
6. Weiden PL and Piandosi S: Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer study group. J Natl Cancer Inst 83: 266-273, 1991.
7. Roussel R , Gümex-Codina J, Camps C et al: A randomized trial comparing preopartive chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 30: 153-158, 1994.
8. Le Chevalier T, Brisgand D, Douillard JY et al: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol 12: 360-367, 1994.
9. Cullen MH, Billingham LJ, Woodroffe CM et al: Mitomycin, ifosfamide and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. J Clin Oncol 17: 3188-3194, 1999.
10. Crino L, Scagliotti GV, Ricci S et al: Gemcitabine and cisplatin versus mitomycin, ifosfamide and cisplatin in advanced non-small-cell lung cancer: a randomized phase III study of the Italian Lung Cancer Project. J Clin Oncol 17: 3522-3530, 1999.
11. Frasci G, Panza N, Comella P et al: Cisplatin, gemcitabine and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: a phase I-II study. J Clin Oncol 17: 2316-2325, 1999.
12. Cardenal F, Lopez-Cabrerizo MP, Anton A et al: Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced metastatic non-small-cell lung cancer. J Clin Oncol 17: 12-18, 1999.
13. Comella P, Frasci G, Panza N et al: Randomized trial comparing cisplatin, gemcitabine and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Oncology Group. J Clin Oncol 18: 1451-1457, 2000.
14. Bonomi P, Kim KM, Fairclough D et al: Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group Trial. J Clin Oncol 18: 623-631, 2000.
15. Greco A and Hainsworth JD: Paclitaxel (1-h infusion) plus carboplatin in the treatment of advanced non-small-cell lung cancer: results of a multicenter phase II trial. Semin Oncol 24: S12-S14, S12-S17, 1997.
16. 2) plus carboplatin in non-small-cell lung cancer: a randomized study. Semin Oncol 24: 12-30 S12-30, S12-33, 1997.
17. Chang AY, De Vore R and Johnson D: Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small-cell lung cancer. Semin Oncol 23: S19-S21, 1996.
18. Belani CP, Keams CM, Zuhowski EG et al: Phase I trial, including pharmacokinetics and pharmacodynamic correlations of combinations paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer. J Clin Oncol 17: 676-684, 1999.
19. Georgoulias V, Kouroussis CH, Androulakis N et al: Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial. J Clin Oncol 17: 914-920, 1999.
20. Iaffaioli RV, Tortoriello A, Facchini G et al: Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer. J Clin Oncol 17: 921-926, 1999.
21. Stathopoulos GP, Veslemes M, Georgatou N et al: Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial. Ann Oncol 15: 1048-1055, 2004.
22. Johnson BE: Integration of new agents into the treatment of advanced non-small-cell lung cancer. American Society of Clinical Oncology Educational Book, pp. 345-356, 2000.
23. Huizing MT, Giaccone G, van Warmerdam LJC et al: Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. J Clin Oncol 15: 317-329, 1997.
24. Miller VA, Krug LM, Ng KK et al: Phase II trail of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer. J Clin Oncol 18: 1346-1350, 2000.
25. Oshita F, Noda K, Nishiwaki Y et al: Phase II study of irinotecan and etoposide in patients with metastatic non-small-cell lung cancer (NSCLC). J Clin Oncol 15: 304-309, 1997.
26. Rusthoven JJ, Eisenhower E, Butts C et al: Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: a phase II study. J Clin Oncol 17: 1194-1199, 1999.
27. Von Pawel J, von Roemeling R, Gatzemeier V et al: Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: a report of the International CATA PULTI Study Group. J Clin Oncol 18: 1351-1359, 2000.
28. Akerly W, Choy H, Safran H et al: Weekly paclitaxel in patients with advanced lung cancer: preliminary data from a phase II trial. Semin Oncol 24: S12-10-S12-13, 1997.
29. Crino L, Scagliotti G, Maragolo M et al: Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study. J Clin Oncol 75: 297-303, 1997.
30. Kouroussis CH, Androulakis N, Kakolyris S et al: First-line treatment of advanced non-small-cell lung carcinoma with docetaxel and vinorelbine. Cancer 83: 2083-2090, 1998.
31. Lorusso V, Carpagnano F, Frasci G et al: Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer. J Clin Oncol 18: 405-411, 2000.
32. Dimitroulis J and Stathopoulos GP: Evolution of non-small-cell lung cancer chemotherapy (Review). Oncol Rep 13: 923-930, 2005.
33. De Pierre A, Chastang CI, Quoix E et al: Vinorelbine plus cisplatin in advanced non-small-cell lung cancer: a randomized trail. Ann Oncol 5: 37-42, 1994.
34. Pectasides D, Aspropotamitis A, Halikia A et al: Combination chemotherapy with carboplatin, docetaxel gemcitabine in advanced non-small-cell lung cancer: a phase II study. J Clin Oncol 17: 3816-3821, 1999.
35. Schmittel A, Siehl JM, Schulze M et al: Phase II trial of carboplatin, paclitaxel plus vinorelbine in non-small-cell lung cancer patients. Anticancer Res 25: 1335-1336, 2005.
36. 2), IIIB and IV non-small-cell lung cancer. Anticancer Res 25: 471-476, 2005.
37. Recchia F, Saggio G, Cesta A et al: Paclitaxel plus gemcitabine in advanced non-small-cell lung cancer patients with low performance status. Anticancer Res 25: 409-414, 2005.